ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression

por Hernández-Llodrà, Silvia, Juanpere, Nuria, de Muga, Silvia, Lorenzo, Marta, Gil, Joan, Font-Tello, Alba, Agell, Laia, Albero-González, Raquel, Segalés, Laura, Merino, José, Serrano, Laia, Fumadó, Lluís, Cecchini, Lluís, Lloreta-Trull, Josep
Publicado 2017

Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma

por Rojo, Federico, González-Pérez, Abel, Furriol, Jessica, Nicolau, Ma Jesús, Ferrer, Jaime, Burgués, Octavio, Sabbaghi, MohammadA, González-Navarrete, Irene, Cristobal, Ion, Serrano, Laia, Zazo, Sandra, Madoz, Juan, Servitja, Sonia, Tusquets, Ignasi, Albanell, Joan, Lluch, Ana, Rovira, Ana, Eroles, Pilar
Publicado 2016

Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case–control study

por Posso, Margarita, Corominas, Josep M., Serrano, Laia, Román, Marta, Torá‐Rocamora, Isabel, Domingo, Laia, Romero, Anabel, Quintana, María Jesús, Vernet‐Tomas, María, Baré, Marisa, Vidal, Carmen, Sánchez, Mar, Saladié, Francina, Natal, Carmen, Ferrer, Joana, Servitja, Sònia, Sala, María, Castells, Xavier, Burón, Andrea, Rodríguez‐Arana, Ana, Romero, Ana, Vernet, Mar, Andreu, Xavier, Milà, Núria, López‐Vilaró, Laura, Fernández‐Somoano, Ana, Galceran, Jaume, Espinàs, Josep Alfons
Publicado 2017